| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/23/2013 | US8426573 Nucleic acids encoding TNFγ |
| 04/23/2013 | US8426188 Attenuated recombinant alphaviruses incapable of replicating in mosquitoes and uses thereof |
| 04/23/2013 | US8426167 Methods for producing fusion polypeptides or enhancing expression of fusion polypeptides |
| 04/23/2013 | US8426147 RORS as modifiers of the p21 pathway and methods of use |
| 04/23/2013 | US8426139 Polypeptides for identifying in vitro and preventing staphyloccocal infections on joint prostheses and other implanted foreign materials |
| 04/23/2013 | US8425922 Adjuvant compositions and methods of use |
| 04/23/2013 | US8425920 Method for inducing lymphoid tissue and modulating intestinal homeostasis |
| 04/23/2013 | US8425919 Recombinant polyprotein vaccines for the treatment and diagnosis of leishmaniasis |
| 04/23/2013 | US8425918 Use of EDTA and its derivatives for prevention and treatment of bacterial intestinal diseases of pigs and for increasing the effects of antibiotics exerted in such diseases |
| 04/23/2013 | US8425917 Mutant forms of EtxB and CtxB and their use as carriers |
| 04/23/2013 | US8425916 Immunizing compositions and methods of use |
| 04/23/2013 | US8425915 Nanoparticles for providing immune responses against infectious agents |
| 04/23/2013 | US8425913 Immunogenic agents against Burkholderia pseudomallei and/or Burkholderia mallei, comprising lipopolysaccharide, capsular polysaccharide and/or proteins from Burkholderia pseudomallei |
| 04/23/2013 | US8425912 Immunoconjugates with an intracellularly-cleavable linkage |
| 04/23/2013 | US8425911 Methods of treating secondary bone tumors with antibodies against PDGFR alpha |
| 04/23/2013 | US8425910 Composition comprising antibodies to LINGO or fragments thereof |
| 04/23/2013 | US8425908 Treatment with anti-ErbB2 antibodies |
| 04/23/2013 | US8425907 Methods for treating pruritus by administering an antibody that specifically binds human PAR2 |
| 04/23/2013 | US8425906 Method to inhibit cancer targeting CD24 |
| 04/23/2013 | US8425905 Antibodies directed against amyloid-beta peptide and methods using same |
| 04/23/2013 | US8425904 Human antibodies that bind mesothelin, and uses thereof |
| 04/23/2013 | US8425903 Methods of treatment by administering antibodies to notch receptors |
| 04/23/2013 | US8425902 Monoclonal antibodies against claudin-18 for treatment of cancer |
| 04/23/2013 | US8425898 Compositions, methods, and kits for eliciting an immune response |
| 04/23/2013 | US8425877 Method for diagnosis of systemic sclerosis involving an anti-AT1-receptor antibody |
| 04/23/2013 | CA2599697C Chemically defined stabiliser composition |
| 04/23/2013 | CA2504818C Anti-cd33 antibodies and method for treatment of acute myeloid leukemia using the same |
| 04/23/2013 | CA2493081C Reagents and methods for engaging unique clonotypic lymphocyte receptors |
| 04/23/2013 | CA2475102C Stabilized synthetic immunogen delivery systems |
| 04/23/2013 | CA2458394C Lipophilic drug compositions |
| 04/23/2013 | CA2416761C Method for screening peptides for use in immunotherapy |
| 04/23/2013 | CA2410563C Methods for preventing strokes by inducing tolerance to e-selectin |
| 04/23/2013 | CA2400838C Novel method for down-regulation of amyloid |
| 04/23/2013 | CA2381125C Ligands for use in therapeutic compositions for the treatment of hemostasis disorders |
| 04/18/2013 | WO2013056248A2 Treatment of breast cancer with companion diagnostic |
| 04/18/2013 | WO2013056240A1 Methods for treating vascular leak syndrome and cancer |
| 04/18/2013 | WO2013056233A1 Treatment of ocular disease |
| 04/18/2013 | WO2013056148A2 Methods of using scd1 antagonists |
| 04/18/2013 | WO2013056122A1 Engineered outer domain (eod) of hv gp120 and mutants thereof |
| 04/18/2013 | WO2013056068A1 Antibody polypeptides that antagonize cd40l |
| 04/18/2013 | WO2013055998A1 ANTI-HtrA1 ANTIBODIES AND METHODS OF USE |
| 04/18/2013 | WO2013055985A1 Combinatorial compositions and methods of treating hemoglobinopathies |
| 04/18/2013 | WO2013055922A1 Use of semaphorin-4d binding molecules for modulation of blood brain barrier permeability |
| 04/18/2013 | WO2013055908A1 An hiv-1 gp120 mini v3 loop and uses thereof |
| 04/18/2013 | WO2013055905A1 Recombinant self-replicating polycistronic rna molecules |
| 04/18/2013 | WO2013055874A2 Uses for and article of manufacture including her2 dimerization inhibitor pertuzumab |
| 04/18/2013 | WO2013055420A2 Novel clostridium difficile dna vaccine |
| 04/18/2013 | WO2013055418A2 Cross-protective arenavirus vaccines and their method of use |
| 04/18/2013 | WO2013055385A2 Methods of treating age related disorders |
| 04/18/2013 | WO2013055326A2 Vaccines for human papilloma virus and methods for using the same |
| 04/18/2013 | WO2013055058A2 Antibody-binding peptide-ferritin fusion protein and uses thereof |
| 04/18/2013 | WO2013054830A1 Monoclonal antibody against el, inhibiting el enzymatic activity |
| 04/18/2013 | WO2013054331A1 Antibodies to carcinoembryonic antigen-related cell adhesion molecule (ceacam) |
| 04/18/2013 | WO2013054320A1 Antibodies to carcinoembryonic antigen-related cell adhesion molecule (ceacam) |
| 04/18/2013 | WO2013054307A2 Antibodies and methods for wnt pathway-related diseases |
| 04/18/2013 | WO2013054199A2 Cmv antigens and uses thereof |
| 04/18/2013 | WO2013054111A1 Improved sperm function/activity |
| 04/18/2013 | WO2013053775A1 Combination medicament comprising il-12 and an agent for blockade of t-cell inhibitory molecules for tumour therapy |
| 04/18/2013 | WO2013053751A1 Compositions for the treatment of rheumatoid arthritis and methods of using same |
| 04/18/2013 | WO2013053694A1 Monoclonal anti-idiotype antibody ganglidiomab |
| 04/18/2013 | WO2013053642A1 Self-assembling peptide nanoparticles as vaccines against infection with norovirus |
| 04/18/2013 | WO2013053641A1 Allergens from insects |
| 04/18/2013 | WO2013053021A1 ANTIBODIES TO CD1d |
| 04/18/2013 | WO2013026452A9 Method for removing immunosuppresive properties of hiv envelope glycoproteins |
| 04/18/2013 | WO2013022991A3 Methods and compositions relating to p62 for the treatment and prophylaxis of cancer |
| 04/18/2013 | WO2013006547A3 Antibodies against epidermal growth factor receptor (egfr) and uses thereof |
| 04/18/2013 | WO2013005194A3 Multispecific mutated antibody fab fragments |
| 04/18/2013 | WO2012160200A8 Tolerogenic dendritic cells and their use in cell therapy |
| 04/18/2013 | WO2012154944A3 Methods of treating autophagy-associated disorders and related pharmaceutical compositions, diagnostics, screening techniques and kits |
| 04/18/2013 | WO2011138251A8 Lentiviral vector based immunological compounds against malaria |
| 04/18/2013 | US20130095549 Tweak receptor |
| 04/18/2013 | US20130095498 Novel group b streptococcus antigens |
| 04/18/2013 | US20130095175 Treating neurological disorders |
| 04/18/2013 | US20130095172 Uses for and article of manufacture including her2 dimerization inhibitor pertuzumab |
| 04/18/2013 | US20130095137 Pan-lyssavirus vaccines against rabies |
| 04/18/2013 | US20130095136 Tetravalent Dengue Vaccines |
| 04/18/2013 | US20130095134 Stabilized virus like particles having enhanced mucosal immunogenicity |
| 04/18/2013 | US20130095133 Pharmaceutical compositions comprising a polypeptide comprising at least one cxxc motif and heterologous antigens and uses thereof |
| 04/18/2013 | US20130095130 Methods and Compositions for Providing Protective Immunity in the Elderly |
| 04/18/2013 | US20130095129 Treatment of immune disease by mucosal delivery of antigens using genetically modified lactobacillus |
| 04/18/2013 | US20130095126 Use of substituted heterocyclic compounds to control sea lice on fish |
| 04/18/2013 | US20130095121 Methods of treating patients with immune-related diseases |
| 04/18/2013 | US20130095119 Compositions and methods for diagnosing and treating an inflammation |
| 04/18/2013 | US20130095118 Use of Semaphorin-4D Binding Molecules for Modulation of Blood Brain Barrier Permeability |
| 04/18/2013 | US20130095116 RSPO Binding Agents and Uses Thereof |
| 04/18/2013 | US20130095114 T Cell Regulation |
| 04/18/2013 | US20130095112 Novel methods for treating egfr-associated tumors |
| 04/18/2013 | US20130095110 Hyaluronic Acid Decomposition-Promoting Factor and Inhibitor Thereof |
| 04/18/2013 | US20130095109 Antibody polypeptides that antagonize cd40l |
| 04/18/2013 | US20130095108 Factor xii inhibitors for treating interstitial lung disease |
| 04/18/2013 | US20130095107 Biomarker specific to brain/nerve or specific to neuronal differentiation |
| 04/18/2013 | US20130095106 Use of trifunctional bispecific and trispecific antibodies for the treatment of malignant ascites |
| 04/18/2013 | US20130095105 Treatment of Ocular Disease |
| 04/18/2013 | US20130095103 Means and methods for the treament of tumorous diseases |
| 04/18/2013 | US20130095101 Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasis |
| 04/18/2013 | US20130095098 Pd-1 antibody |
| 04/18/2013 | US20130095095 Method for treating thrombotic disorders using quercetin-containing compositions |
| 04/18/2013 | US20130095093 Methods and compositions for treatment of immune dysfunction disorders |
| 04/18/2013 | US20130095069 Method of treating autoimmune diseases with interferon-beta and il-2r antagonist |
| 04/18/2013 | US20130095065 Methods for Treating Vascular Leak Syndrome and Cancer |